Medline, Inc. (MDLN)
39.17
-0.30
(-0.76%)
USD |
NASDAQ |
Nov 16, 16:00
38.43
-0.74
(-1.89%)
After-Hours: 05:36
Medline Price to Book Value : 2.918 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 2.918 |
| November 13, 2026 | 2.940 |
| November 12, 2026 | 2.978 |
| November 11, 2026 | 3.140 |
| November 10, 2026 | 3.047 |
| November 09, 2026 | 3.032 |
| November 06, 2026 | 2.953 |
| November 05, 2026 | 2.962 |
| November 04, 2026 | 3.006 |
| November 03, 2026 | 2.539 |
| November 02, 2026 | 2.505 |
| October 30, 2026 | 2.392 |
| October 29, 2026 | 2.384 |
| October 28, 2026 | 2.411 |
| October 27, 2026 | 2.412 |
| October 26, 2026 | 2.509 |
| October 23, 2026 | 2.539 |
| October 22, 2026 | 2.598 |
| October 21, 2026 | 2.630 |
| October 20, 2026 | 2.641 |
| October 19, 2026 | 2.621 |
| October 16, 2026 | 2.678 |
| October 15, 2026 | 2.724 |
| October 14, 2026 | 2.676 |
| October 13, 2026 | 2.659 |
| Date | Value |
|---|---|
| October 12, 2026 | 2.664 |
| October 09, 2026 | 2.701 |
| October 08, 2026 | 2.662 |
| October 07, 2026 | 2.640 |
| October 06, 2026 | 2.648 |
| October 05, 2026 | 2.667 |
| October 02, 2026 | 2.652 |
| October 01, 2026 | 2.602 |
| September 30, 2026 | 2.585 |
| September 29, 2026 | 2.651 |
| September 28, 2026 | 2.658 |
| September 25, 2026 | 2.630 |
| September 24, 2026 | 2.627 |
| September 23, 2026 | 2.600 |
| September 22, 2026 | 2.609 |
| September 21, 2026 | 2.422 |
| September 18, 2026 | 2.398 |
| September 17, 2026 | 2.434 |
| September 16, 2026 | 2.500 |
| September 15, 2026 | 2.434 |
| September 14, 2026 | 2.470 |
| September 11, 2026 | 2.465 |
| September 10, 2026 | 2.455 |
| September 09, 2026 | 2.580 |
| September 08, 2026 | 2.629 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Abbott Laboratories | 3.647 |
| AngioDynamics, Inc. | 3.048 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.281 |
| Baxter International, Inc. | 2.032 |
Price to Book Value Related Metrics
| PE Ratio | 58.55 |
| PS Ratio | 1.217 |
| Price to Free Cash Flow | 19.87 |
| Price | 39.17 |
| Earnings Yield | 1.71% |
| Market Cap | 34.43B |
| Operating PE Ratio | 18.84 |
| Normalized PE Ratio | 32.10 |